Board of Directors
Horst G. Zerbe, Ph.D., CEO, IntelGenx Corp.
J. Bernard Boudreau Sr. VP, PharmEng Inc. Prior to joining the pharmaceutical industry, Mr. Boudreau served as the Minister of Finance and Minister of Health of the provincial government of Nova Scotia.
David Coffin-Beach, Ph.D., President, ATP Solutions, Inc. As the former President and CEO of TorPharm and Associate Director at Schering Plough, Dr. Coffin-Beach brings a wealth of experience in the pharmaceutical industry to the table.
Joel Cohen, CFA, has extensive experience in biotechnology financings and in financial analysis. He is a former investment banker at Canaccord Capital, where he specialized in biotechnology financings. He has worked on numerous IPOs, private and public financings for various companies.
Ian Troup, B.Sc. has more than 40 years of experience in the pharmaceutical industry, most recently serving as President and Chief Operating Officer of Upsher-Smith Laboratories, a privately held generic pharmaceutical company, prior to which he was President of Schwarz Pharma USA. He is currently an active board member of several Minneapolis-based businesses including Vital Medix, an early stage drug development company, Medisyn Technologies, a privately funded corporation involved in computer based topological drug design, and TwinWest PAC, a political action committee helping Minnesota businesses gain local, state and federal access to political officials.